(Q42679270)

4 November 2017

Long-term tolerability and efficacy of lamotrigine in pediatric patients with epilepsy (English)

1 reference

4 November 2017

1 reference

Michael Duchowny

1

1 reference

4 November 2017

Jamie Gilman

2

1 reference

4 November 2017

John Messenheimer

3

1 reference

4 November 2017

Gilda Womble

4

1 reference

4 November 2017

Marcus Risner

5

1 reference

4 November 2017

LAMICTAL Pediatric Study Group

6

1 reference

4 November 2017

1 April 2002

1 reference

Journal of Child Neurology

4 November 2017

1 reference

4 November 2017

17

1 reference

4 November 2017

4

1 reference

4 November 2017

278-285

1 reference

The neurobiology and consequences of epilepsy in the developing brain

4 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700408

Quality of life of people with epilepsy: a European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700408

A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700408

Lamictal (lamotrigine) monotherapy for typical absence seizures in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700408

Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700408

Lamotrigine for the treatment of epilepsy in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700408

Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700408

Lamotrigine treatment in childhood drug resistant epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700408

Lamotrigine in Rett syndrome: treatment experience from a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700408

Safety review of adult clinical trial experience with lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700408

Differential cognitive and behavioral effects of carbamazepine and lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700408

Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700408

The tolerability of lamotrigine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700408

Validation of a population pharmacokinetic model for adjunctive lamotrigine therapy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700408

Long-term safety and efficacy of lamotrigine (Lamictal) in paediatric patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700408

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700408

10.1177/088307380201700408

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference